An unusual presentation of neonatal rhabdomyosarcoma: a case report
Affiliation
Department of Pediatrics (Neonatology), Banner University Medical Center, University of ArizonaDepartment of Pathology, Phoenix Children’s Hospital—University of Arizona, Phoenix
|Department of Pediatrics (Hematology/Oncology), Banner University Medical Center, University of Arizona
Issue Date
2023-10-27
Metadata
Show full item recordPublisher
Frontiers Media SACitation
Strah D, Stanley K, Oatmen K, Kylat RI, Dishop M and de la Maza M (2023) An unusual presentation of neonatal rhabdomyosarcoma: a case report. Front. Pediatr. 11:1233334. doi: 10.3389/fped.2023.1233334Journal
Frontiers in PediatricsRights
© 2023 Strah, Stanley, Oatmen, Kylat, Dishop and de la Maza. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
A full-term infant with an unremarkable prenatal course presented at birth with a large midline facial mass and smaller masses in the head and neck. In addition, multiple diffuse flesh-colored nodules spread along all the upper and lower limbs. An extensive evaluation to cover a broad differential diagnosis of infectious, lymphatic/vascular, and oncologic etiology was undertaken. The initial suspicion was confirmed by biopsy of the skin lesion as congenital alveolar rhabdomyosarcoma (RMS). RMS is the most common soft tissue sarcoma that occurs in childhood. However, neonatal RMS is exceedingly rare. The infant’s initial treatment included vincristine, dactinomycin, and cyclophosphamide in addition to salvage ifosfamide and etoposide, which were dose-adjusted for age. Herein, we present a case of an infant with RMS who showed initial improvement before relapsing and succumbing to her disease at 5 months of age. A review of the limited literature available on this rare condition and newer treatment regimens with improved mortality rates is performed. 2023 Strah, Stanley, Oatmen, Kylat, Dishop and de la Maza.Note
Open access journalISSN
2296-2360Version
Final Published Versionae974a485f413a2113503eed53cd6c53
10.3389/fped.2023.1233334
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © 2023 Strah, Stanley, Oatmen, Kylat, Dishop and de la Maza. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).

